Immuneering's total assets for Q3 2025 were $241.06M, an increase of 501.79% from the previous quarter. IMRX total liabilities were $13.08M for the fiscal quarter, a 17.62% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.